Wells Fargo’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,172
| Closed | -$5.64K | – | 7340 |
|
|
2023
Q3 | $5.64K | Buy |
1,172
+4
| +0.3% | +$19 | ﹤0.01% | 5564 |
|
|
2023
Q2 | $4.54K | Buy |
1,168
+1
| +0.1% | +$4 | ﹤0.01% | 5782 |
|
|
2023
Q1 | $2.93K | Hold |
1,167
| – | – | ﹤0.01% | 5848 |
|
|
2022
Q4 | $2.12K | Sell |
1,167
-1
| -0.1% | -$2 | ﹤0.01% | 5676 |
|
|
2022
Q3 | $8K | Hold |
1,168
| – | – | ﹤0.01% | 5466 |
|
|
2022
Q2 | $13K | Buy |
1,168
+1
| +0.1% | +$11 | ﹤0.01% | 5366 |
|
|
2022
Q1 | $26K | Hold |
1,167
| – | – | ﹤0.01% | 5593 |
|
|
2021
Q4 | $33K | Buy |
1,167
+633
| +119% | +$17.9K | ﹤0.01% | 5679 |
|
|
2021
Q3 | $36K | Sell |
534
-2
| -0.4% | -$135 | ﹤0.01% | 5439 |
|
|
2021
Q2 | $43K | Buy |
536
+209
| +64% | +$16.8K | ﹤0.01% | 5309 |
|
|
2021
Q1 | $44K | Sell |
327
-618
| -65% | -$83.2K | ﹤0.01% | 5525 |
|
|
2020
Q4 | $151K | Buy |
945
+224
| +31% | +$35.8K | ﹤0.01% | 5053 |
|
|
2020
Q3 | $75K | Sell |
721
-178
| -20% | -$18.5K | ﹤0.01% | 5150 |
|
|
2020
Q2 | $109K | Buy |
899
+324
| +56% | +$39.3K | ﹤0.01% | 4979 |
|
|
2020
Q1 | $45K | Sell |
575
-223
| -28% | -$17.5K | ﹤0.01% | 5152 |
|
|
2019
Q4 | $235K | Sell |
798
-182
| -19% | -$53.6K | ﹤0.01% | 4710 |
|
|
2019
Q3 | $178K | Sell |
980
-14
| -1% | -$2.54K | ﹤0.01% | 4837 |
|
|
2019
Q2 | $396K | Sell |
994
-64
| -6% | -$25.5K | ﹤0.01% | 4414 |
|
|
2019
Q1 | $494K | Buy |
1,058
+147
| +16% | +$68.6K | ﹤0.01% | 4289 |
|
|
2018
Q4 | $438K | Buy |
911
+630
| +224% | +$303K | ﹤0.01% | 4287 |
|
|
2018
Q3 | $192K | Buy |
281
+23
| +9% | +$15.7K | ﹤0.01% | 4849 |
|
|
2018
Q2 | $176K | Buy |
+258
| New | +$176K | ﹤0.01% | 4910 |
|